Know Cancer

or
forgot password

Application of Megavoltage Imaging to Reduce Artifact Following Interstitial Seed Implants for Prostate Adenocarcinoma


N/A
50 Years
80 Years
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information

Application of Megavoltage Imaging to Reduce Artifact Following Interstitial Seed Implants for Prostate Adenocarcinoma


Inclusion Criteria:



Male 50-80 years of age Eligible for interstitial brachytherapy implants

Exclusion Criteria:

-

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Change in prostate volume measured in cm^3

Outcome Description:

Change in prostate volume measured with trans-rectal ultrasound at baseline versus prostate volume measured with KVCT and MVCT.

Outcome Time Frame:

One month post implant

Safety Issue:

No

Principal Investigator

William St. Clair, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Lucille P. Markey Cancer Center at University of Kentucky

Authority:

United States: Food and Drug Administration

Study ID:

13-RAD-01

NCT ID:

NCT01810627

Start Date:

March 2013

Completion Date:

April 2015

Related Keywords:

  • Prostate Cancer
  • Prostate
  • Cancer
  • Prostatic Neoplasms

Name

Location

Markey Cancer CenterLexington, Kentucky  40536